SSZ

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

SSZ is a multi-target inhibitor, which targets multiple pathological mechanisms of Alzheimer's disease (AD). SSZ targets acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein cleavage enzyme 1 (BACE1), and γ-secretase. SSZ ameliorates Alzheimer’s diseases and exhibits neuroprotective effect in mice.

For research use only. We do not sell to patients.

  • Purity: 98.13%
  • CAS No.: 1262287-23-9
  • Formula: C18H19ClN4
  • Molecular Weight:326.82
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) SSZ

More

All Cholinesterase (ChE) Isoforms

More

All Beta-secretase Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00